Northwest Biotherapeutics Announces That It Has No Banking Relationship With SVB

Provided By PR Newswire

Last update: Mar 12, 2023

BETHESDA, Md., March 11, 2023 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax^® personalized immune therapies for solid tumor cancers, today announced that it has no banking relationship with Silicon Valley Bank (SVB) and no funds on deposit at SVB.